V. Lakner

发表

Long-term follow-up of rituximab plus first-line mitoxantrone, chlorambucil, prednisolone and interferon-alpha as maintenance therapy in follicular lymphoma

R. Naumann, M. Herold, F. Rothmann, 2015, Journal of Cancer Research and Clinical Oncology.

Phase II study of capecitabine plus trastuzumab in human epidermal growth factor receptor 2 overexpressing metastatic breast cancer pretreated with anthracyclines or taxanes.

A. Hinke, G. Schaller, P. Klare, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Results of a Prospective Randomised Open Label Phase III Study Comparing Rituximab Plus Mitoxantrone, Chlorambucile, Prednisolone Chemotherapy (R-MCP) Versus MCP Alone in Untreated Advanced Indolent Non-Hodgkin’s Lymphoma (NHL) and Mantle-Cell-Lymphoma (MCL).

D. Niederwieser, T. Ittel, R. Naumann, 2004 .

[Lymphatic outflow scintigraphy in a case of artificial edema of the lower limb].

C. Kittner, S. Decker, V. Lakner, 1994, Nuklearmedizin. Nuclear medicine.

Second-line oxaliplatin, folinic acid, and fluorouracil versus folinic acid and fluorouracil alone for gemcitabine-refractory pancreatic cancer: outcomes from the CONKO-003 trial.

B. Dörken, M. Görner, T. Greten, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Diffuse gastric antral vascular ectasia: cause of chronic gastrointestinal blood loss.

M. Barten, T. Arendt, V. Lakner, 1987, Endoscopy.

Long-Term Results in Adult AML: Comparison of Postremission Chemotherapy vs. Autologous BMT vs. Allogeneic BMT

M. Stauch, R. Schubert, R. Rohrberg, 1996 .

Two new missense mutations in a non-Jewish Caucasian family with type 3 Gaucher disease

A. Rolfs, G. Grau, P. Seeman, 1996, Neurology.

Fludarabine and Bendamustine in Refractory and Relapsed Indolent Lymphoma—a Multicenter Phase I/II Trial of the East German Society of Hematology and Oncology (OSHO)

M. Herold, M. Assmann, H. Eschenburg, 2004, Leukemia & lymphoma.

No advantage of Imatinib in combination with hydroxyurea over Imatinib monotherapy: a study of the East German Study Group (OSHO) and the German CML study group

D. Niederwieser, C. Junghanss, M. Cross, 2020, Leukemia & lymphoma.

[Secretory immunoglobulin A].

J. Brock, V. Lakner, 1977, Allergie und Immunologie.

Second-line oxaliplatin, folinic acid, and fluorouracil versus folinic acid and fluorouracil alone for gemcitabine-refractory pancreatic cancer: outcomes from the CONKO-003 trial.

B. Dörken, M. Görner, T. Greten, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.